0001203311-23-000014.txt : 20230215 0001203311-23-000014.hdr.sgml : 20230215 20230215183318 ACCESSION NUMBER: 0001203311-23-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230213 FILED AS OF DATE: 20230215 DATE AS OF CHANGE: 20230215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRYSKA DAVID W CENTRAL INDEX KEY: 0001202335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23636682 MAIL ADDRESS: STREET 1: 749 N MARY AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2023-02-13 0 0001060736 Seagen Inc. SGEN 0001202335 GRYSKA DAVID W 21823 30TH DRIVE SE BOTHELL WA 98021 1 0 0 0 Common Stock 2023-02-13 4 M 0 8750 36.7 A 49003 D Non-Qualified Stock Option (right to buy) 36.7 2023-02-13 4 M 0 8750 0.0 D 2023-05-17 Common Stock 8750 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Options were fully vested on 5/16/14. By: /s/ Jennifer Prosba For: David W. Gryska 2023-02-15